title: [Complementary and Alternative Medicine (CAM) in Uro-Oncology].
abstract: The West German Comprehensive Cancer Center is confronted with more than 30 000 questions per year concerning unconventional anti-cancer strategies. Unconventional or complementary drugs are not to be compared with placebos. Similar to cytotoxic drugs, unconvetional drugs have to be tested according to the guidelines of <<good clinical practice>> (GCP). An adjuvant treatment with unconventional drugs is not indicated. Because an possible immunomodulating effect, long-term results have to be considered - especially related to tumor progression. Right now a routine application of unconventional drugs is not indicated in the field of urological oncology.
authors: Westdeutsches Tumorzentrum Essen, Deutschland.
authors: J
authors: J
authors: Suhr
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D000529:Complementary Therapies; D006801:Humans; D008517:Phytotherapy; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014571:Urologic Neoplasms / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents